ClinicalTrials.Veeva

Menu
S

Saxenburgh Medisch Centrum | Cardiology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
Apixaban
Ezetimibe
Tirzepatide
LY3819469
LY3298176

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

The main purpose of this study is to determine the efficacy and safety of LY3819469 in adults with elevated lipoprotein(a). The study will lasts abou...

Active, not recruiting
Lipoprotein Disorder
Drug: Placebo
Drug: LY3819469

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

Trial sponsors

Lilly logo
Daiichi Sankyo logo
Novo Nordisk logo
Bayer logo
Netherlands Cancer Institute (NKI) logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems